---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---
<div align="justify">

<p>
Over the past two decades, my research has focused on bridging computational prediction with biological validation to understand how small molecules influence disease networks. These efforts have resulted in a growing body of peer-reviewed publications across infectious disease therapeutics, cardioprotection, molecular modeling, and systems pharmacology.
</p>

<p>
A complete and automatically updated list is available on <a href="https://scholar.google.com/citations?user=EnEq7LkAAAAJ&hl=en" target="_blank">Google Scholar</a>.
</p>

<h3>2023</h3>
<ul>
  <li><a href="/publications/2023-antibiofilm-design/">In silico and in vivo methods for designing antibiofilm agents against <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> (Book Chapter)</a></li>
  <li><a href="/publications/2023-smart-surfaces-review/">Multi-functional approach in the design of smart surfaces to mitigate bacterial infections, a review</a></li>
  <li><a href="/publications/2023-eskape-qS-review/">Revisiting ESKAPE Pathogens, virulence, resistance, and combating strategies focusing on quorum sensing</a></li>
  <li><a href="/publications/2023-cauti-innovations/">Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection, a review</a></li>
</ul>

<h3>2022</h3>
<ul>
  <li><a href="/publications/2022-peptidomimetic-qS-review/">A prospective diversity of antibacterial small peptidomimetic and quorum sensing mediated drug, a review</a></li>
  <li><a href="/publications/2022-fisetin-ifm-protection/">Fisetin preserves interfibrillar mitochondria to protect against myocardial ischemia–reperfusion injury</a></li>
  <li><a href="/publications/2022-ct-eo-nanoemulsion-diabetes/">Multi-target interactions of essential oil nanoemulsion of <i>Cinnamomum travancoricum</i> against diabetes mellitus</a></li>
  <li><a href="/publications/2022-gyrb-inhibitor-design/">Design, dynamic docking, synthesis, and in vitro validation of a novel DNA gyrase B inhibitor</a></li>
</ul>

<h3>2021</h3>
<ul>
  <li><a href="/publications/2021-fisetin-risk-pathway/">Fisetin attenuates myocardial ischemia–reperfusion injury by activating the RISK pathway</a></li>
</ul>

<h3>2020</h3>
<ul>
  <li><a href="/publications/2020-micromonospora-vibrio/">Anti-infectives from mangrove-derived <i>Micromonospora</i> to combat <i>Vibrio cholerae</i> pathogenesis</a></li>
  <li><a href="/publications/2020-tc-f-chx-smutans/">Combinatorial effects of trans-cinnamaldehyde with fluoride and chlorhexidine on <i>Streptococcus mutans</i></a></li>
  <li><a href="/publications/2020-dmtu-oral-biofilms/">1,3-di-m-tolyl-urea inhibits and disrupts multispecies oral biofilms</a></li>
  <li><a href="/publications/2020-guardian-genes-smutans/">Guardian genes ensuring subsistence of oral <i>Streptococcus mutans</i></a></li>
</ul>

<h3>2018–2017</h3>
<ul>
  <li><a href="/publications/2018-fisetin-omcl/">Fisetin confers cardioprotection against ischemia–reperfusion injury via mitochondrial protection and GSK3β inhibition</a></li>
  <li><a href="/publications/2017-sts-preconditioning/">Sodium thiosulfate preconditioning ameliorates ischemia/reperfusion injury in rat hearts</a></li>
</ul>

<h3>2015–2011</h3>
<ul>
  <li><a href="/publications/2015-luxo-inhibitors-vcholerae/">Design of LuxO-based inhibitors for anti-virulent cholera therapy</a></li>
  <li><a href="/publications/2014-cqsS-agonist-cai1/">Molecular characterization of cholera autoinducer-1 mimic as a CqsS receptor agonist</a></li>
  <li><a href="/publications/2014-spyogenes-hyaluronidase/">The enzymology of <i>Streptococcus pyogenes</i> hyaluronidase</a></li>
  <li><a href="/publications/2014-classII-hdac-hotspots/">Energy-optimised pharmacophore hotspots for Class II HDAC inhibition</a></li>
  <li><a href="/publications/2013-melia-dubia-sdia-vscreen/">Virtual screening of SdiA inhibitors from <i>Melia dubia</i> against UPEC quorum sensing</a></li>
  <li><a href="/publications/2013-synthetic-quercetin-mtb-gyrase/">Synthetic quercetin inhibits mycobacterial growth via DNA gyrase interaction</a></li>
  <li><a href="/publications/2012-melia-dubia-seed-extracts-upec/">Screening SdiA inhibitors from <i>Melia dubia</i> seed extracts toward UPEC QS factors</a></li>
  <li><a href="/publications/2011-agn-silver-nps/">Biosynthesis of silver nanoparticles by <i>Aspergillus niger</i></a></li>
  <li><a href="/publications/2011-human-aromatase-eisd/">Enzyme–inhibitor interactions of the first experimentally determined human aromatase</a></li>
  <li><a href="/publications/2011-sdia-plant-ligands-ejmc/">Structure-based VS for plant-derived SdiA-selective antivirulent ligands</a></li>
</ul>

</div>
